ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
6 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
16K
|
2.7M
|
6
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
8 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Human Trialing Commencement in 60 Days
|
|
kpax
|
35 |
7.2K |
1 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
35
|
7.2K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
kpax
|
86 |
17K |
11 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
86
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Human Trialing Commencement in 60 Days
|
|
kpax
|
35 |
7.2K |
9 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
35
|
7.2K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
kpax
|
86 |
17K |
22 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
86
|
17K
|
22
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
7 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
kpax
|
86 |
17K |
12 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
86
|
17K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
kpax
|
86 |
17K |
24 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
86
|
17K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
|
|
kpax
|
86 |
17K |
22 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
86
|
17K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
14 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
1.4K
|
377K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
25 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
1.4K
|
377K
|
25
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
2 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
4 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
IVX |
Re:
IVXO options fair value calculation
|
|
kpax
|
16 |
10K |
11 |
06/02/22 |
06/02/22 |
ASX - By Stock
|
16
|
10K
|
11
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
4 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
1
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
16K
|
2.7M
|
1
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
2 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
3 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
3
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
3 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
3
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
2 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
6 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
6
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
8 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
8 |
24/01/22 |
24/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
6 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
6
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
1 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
16K
|
2.7M
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
25 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
1.4K
|
377K
|
25
|
|
ASX - By Stock
|
CVN |
Re:
Ann: Buffalo-10 Drilling Update
|
|
kpax
|
153 |
78K |
3 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
153
|
78K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
21 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
1.4K
|
377K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
30 |
14/01/22 |
14/01/22 |
ASX - By Stock
|
1.4K
|
377K
|
30
|
|
ASX - By Stock
|
PAA |
Re:
Top 20 Holders - 31/12/21
|
|
kpax
|
17 |
5.2K |
4 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
17
|
5.2K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Top 20 Holders - 31/12/21
|
|
kpax
|
17 |
5.2K |
7 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
17
|
5.2K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
24 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
1.4K
|
377K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Top 20 Holders - 31/12/21
|
|
kpax
|
17 |
5.2K |
20 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
17
|
5.2K
|
20
|
|
ASX - By Stock
|
C6C |
Re:
Ann: Copper Mountain Announces Updated Development Plan For Eva
|
|
kpax
|
16 |
7.8K |
1 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
16
|
7.8K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Merry Xmas
|
|
kpax
|
29 |
6.7K |
22 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
29
|
6.7K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 29/11/2021
|
|
kpax
|
15 |
4.9K |
26 |
28/12/21 |
28/12/21 |
ASX - By Stock
|
15
|
4.9K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 29/11/2021
|
|
kpax
|
15 |
4.9K |
7 |
27/12/21 |
27/12/21 |
ASX - By Stock
|
15
|
4.9K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 29/11/2021
|
|
kpax
|
15 |
4.9K |
12 |
27/12/21 |
27/12/21 |
ASX - By Stock
|
15
|
4.9K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
15 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
25 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
20 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
16 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
19 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
24 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
18 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
1.4K
|
377K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Option Holders as at 29/11/2021
|
|
kpax
|
15 |
4.9K |
2 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
15
|
4.9K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection
|
|
kpax
|
103 |
29K |
42 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
103
|
29K
|
42
|
|